XRCC1 and xeroderma pigmentosum group D: Downregulation of GLI1 in cisplatin-treated ovarian cancer cells blocked the expression of c-JUN along with excision repair cross-complementing 1 (ERCC1), XRCC1 and xeroderma pigmentosum group D (XPD) (Figure 2B).